Trust Co. of Vermont Acquires Shares of 4,224 Intuitive Surgical, Inc. $ISRG

Posted by Brenda Bartman on Aug 19th, 2026

Trust Co. of Vermont acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 4,224 shares of the medical equipment provider’s stock, valued at approximately $1,680,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Main Street Group LTD acquired a new position in shares of Intuitive Surgical in the first quarter valued at about $30,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $31,000. Vermillion Wealth Management Inc. raised its stake in Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares in the last quarter. Turning Point Benefit Group Inc. raised its stake in Intuitive Surgical by 833.3% in the 4th quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after purchasing an additional 50 shares in the last quarter. Finally, Motiv8 Investments LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at about $34,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, Director Gary S. Guthart sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director directly owned 1,245,679 shares in the company, valued at $498,271,600. This trade represents a 0.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the transaction, the director owned 251 shares of the company’s stock, valued at approximately $95,129. The trade was a 61.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 17,070 shares of company stock worth $6,933,986. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $391.18 on Wednesday. The company’s 50 day moving average price is $390.17 and its two-hundred day moving average price is $438.79. The firm has a market capitalization of $138.20 billion, a P/E ratio of 44.81, a P/E/G ratio of 2.85 and a beta of 1.47. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period in the prior year, the business earned $1.81 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. On average, analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on ISRG. Raymond James Financial restated an “outperform” rating and set a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. HSBC cut Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research note on Thursday, July 30th. Wells Fargo & Company restated an “overweight” rating and set a $487.00 price objective (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. BNP Paribas Exane raised Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Finally, TD Cowen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Twenty-two research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.

Read Our Latest Stock Analysis on Intuitive Surgical

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.